Translating published and local evidence into pharmaceutical policy for early Alzheimer's disease: An evaluation of criteria for classifying patients as proven to 'benefit' in assessment-based drug-coverage.

Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
Kristine Marie
Principal Investigator Last Name
VOTOVA
Awardee Organization
Contact PI Country
Project Detail
FY Overall Cost
$28,333
Funding Organization
Funding Organization Country